Ethics Talk: Health Hazards of Cost Sharing
In this video and audio edition of Ethics Talk, journal editor in chief, Dr Audiey Kao, talks with Dr Ziad Obermeyer about the potential impact on mortality of cost-sharing practices of health insurers.
Click here to read the transcript.
Ziad Obermeyer, MD, MPhil is the Blue Cross of California Distinguished Associate Professor of Health Policy and Management, UC Berkeley School of Public Health.
Video
Recorded on March 9, 2021
Audio
Conflict of Interest Disclosure
Interviewee reports having equity stakes in Deep Health Dandelion Health and Berkeley Data Ventures as well as receiving speaking and consulting fees from Independence Blue Cross and Anthem.
Viewpoints expressed are those of interview participants and do not necessarily reflect the views and policies of the AMA.
Issue
Racial and Ethnic Health Equity in the US: Part 2
CME
Off
Ethics Talk: Anti-Asian Racism During COVID and Beyond
In this video and podcast edition of Ethics Talk, journal editor in chief, Dr Audiey Kao, talks with Dr Vivian Shaw and Susanna Park about the resurgence of anti-Asian racism and xenophobia during the COVID-19 pandemic.
Click here to read the transcript.
Vivian Shaw, PhD is a College Fellow in the Department of Sociology at Harvard University.
Susanna Park, MA is a PhD candidate at Oregon State University College of Public Health and Human Sciences.
Video
Recorded on April 19, 2021
Audio
Conflict of Interest Disclosure
Interviewees had no conflicts of interest to disclose.
Viewpoints expressed are those of interview participants and do not necessarily reflect the views and policies of the AMA.
Issue
Compassionate Force
CME
Off
Ethics Talk: Could Trusting Science Mean Not Trusting Some FDA Decisions?
In this video and audio edition of Ethics Talk, journal editor in chief, Dr Audiey Kao, talks with Dr Caleb Alexander about the US Food and Drug Administration's controversial decision to approve aducanumab for the treatment of Alzheimer's Disease.
Click here to read the transcript.
G. Caleb Alexander, MD, MS is professor of epidemiology and medicine at Johns Hopkins Bloomberg School of Public Health.
Video
Recorded on June 22, 2021
Neurology Patient Care
Audio
Conflict of Interest Disclosure
Dr Alexander is past chair and current member of FDA's Peripheral and Central Nervous System Drugs Advisory Committee. He is a co-founding principal and equity holder in Monument Analytics, a health care consultancy whose clients include the life sciences industry as well as plaintiffs in opioid litigation. He was also a member of OptumRx's National Pharmacy and Therapeutics Committee.
Viewpoints expressed are those of interview participants and do not necessarily reflect the views and policies of the AMA.
Issue
Visibility and Measurability in Health Care
Off
